Cryosite Limited (CTE.AX)
- Previous Close
0.8700 - Open
0.8400 - Bid 0.8500 x 590000
- Ask 0.8700 x 1533900
- Day's Range
0.8400 - 0.8500 - 52 Week Range
0.5050 - 0.8700 - Volume
61,196 - Avg. Volume
6,248 - Market Cap (intraday)
41.488M - Beta (5Y Monthly) 0.54
- PE Ratio (TTM)
28.33 - EPS (TTM)
0.0300 - Earnings Date Feb 22, 2024
- Forward Dividend & Yield 0.07 (7.65%)
- Ex-Dividend Date Feb 21, 2024
- 1y Target Est
--
Cryosite Limited offers outsourced clinical trials logistic services in Australia. It operates through two segments, Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological, as well as logistics services to the clinical trials, research, and pharmaceutical industries. The Cord Blood and Tissues Storage segment offers long term storage solutions for cord blood and tissue samples. It serves research, medical, pharmaceutical, and biotechnology industries. The company was incorporated in 1999 and is based in South Granville, Australia.
www.cryosite.comRecent News: CTE.AX
Performance Overview: CTE.AX
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CTE.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CTE.AX
Valuation Measures
Market Cap
41.49M
Enterprise Value
38.09M
Trailing P/E
26.32
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.29
Price/Book (mrq)
14.33
Enterprise Value/Revenue
3.02
Enterprise Value/EBITDA
14.77
Financial Highlights
Profitability and Income Statement
Profit Margin
12.49%
Return on Assets (ttm)
5.17%
Return on Equity (ttm)
63.71%
Revenue (ttm)
12.62M
Net Income Avi to Common (ttm)
1.58M
Diluted EPS (ttm)
0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
5.93M
Total Debt/Equity (mrq)
87.26%
Levered Free Cash Flow (ttm)
1.7M
Company Insights: CTE.AX
CTE.AX does not have Company Insights